1. Treating Disease Mechanisms in Patients With Heart Failure and Diabetes Mellitus

   • Amanda Trang
   • David Aguilar

   Comorbidities of Heart Failure (C Angermann and F Edelmann, Section Editors) 02 November 2017 Pages: 445 - 453

2. MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential

   • Palak Shah
   • Michael R. Bristow
   • J. David Port

   Pharmacologic Therapy (W H W Tang, Section Editor) 22 September 2017 Pages: 454 - 464

   

3. Prevention and Treatment of Thrombotic and Hemorrhagic Complications in Patients Supported by Continuous-Flow Left Ventricular Assist Devices

   • Renzo Y. Loyaga-Rendon
   • Milena Jani
   • Sangjin Lee

   Pharmacologic Therapy (W H W Tang, Section Editor) 26 October 2017 Pages: 465 - 477

   

4. Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure

   • Anett H. Ottesen
   • Geir Christensen
   • Helge Røsjø

   Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (S Katz, Section Editor) 03 October 2017 Pages: 478 - 488

   

5. Skeletal muscle alterations in HFrEF vs. HFpEF

   • Volker Adams
   • Axel Linke
   • Ephraim Winzer

   Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (S Katz, Section Editor) 22 September 2017 Pages: 489 - 497

   

6. Defining Ambulatory Advanced Heart Failure: MedaMACS and Beyond

   • Garrick C. Stewart
   • Amrut V. Ambardekar
   • Michelle M. Kittleson

   Prevention of Heart Failure (M. St. John Sutton, Section Editor) 26 September 2017 Pages: 498 - 506

   

7. Pulmonary Hypertension Due to Left Ventricular Cardiomyopathy: Is it the Result or Cause of Disease Progression?

   • Srinath Adusumalli
   • Jeremy A. Mazurek

   Prevention of Heart Failure (M. St. John Sutton, Section Editor) 23 October 2017 Pages: 507 - 513

   

8. High-Risk Percutaneous Coronary Intervention in Public Reporting States: the Evidence, Exclusion of Critically Ill Patients, and Implications

   • Rishi K. Wadhera
   • Jordan D. Anderson
   • Robert W. Yeh

   Prevention of Heart Failure (M. St. John Sutton, Section Editor) 04 November 2017 Pages: 514 - 518

   

9. Visceral Congestion in Heart Failure: Right Ventricular Dysfunction, Splanchnic Hemodynamics, and the Intestinal Microenvironment

   • Vincenzo B. Polsinelli
   • Arjun Sinha
   • Sanjiv J. Shah

   Prevention of Heart Failure (M Sutton, Section Editor) 26 October 2017 Pages: 519 - 528

   

10. Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure

    • Kishan S. Parikh
    • Jonathan P. Piccini

    Genetics of Heart Failure (K Adams, Section Editor) 03 October 2017 Pages: 529 - 535

    

11. Pharmacogenomics of the Natriuretic Peptide System in Heart Failure

    • Ahmed Abuzaanona
    • David Lanfear

    Genetics of Heart Failure (K Adams, Section Editor) 27 October 2017 Pages: 536 - 542

12. Clinical Application of Genetic Testing in Heart Failure

    • Ana Morales
    • Ray Hershberger

    Genetics of Heart Failure (K Adams, Section Editor) 23 October 2017 Pages: 543 - 553